Monitoring in clinical trials of complementary and alternative medicine

被引:4
作者
Jung, So-Young [1 ]
Kang, Jung Won [2 ]
Kim, Tae-Hun [3 ]
机构
[1] Korea Inst Oriental Med, Div Clin Res, Daejeon, South Korea
[2] Kyung Hee Univ, Dept Acupuncture & Moxibust, Coll Korean Med, Seoul, South Korea
[3] Kyung Hee Univ, Korean Med Hosp, Korean Med Clin Trial Ctr, Seoul, South Korea
关键词
Monitoring; Complementary and alternative medicine; CAM; Quality assurance; Quality control; Clinical study; QUALITY;
D O I
10.1016/j.imr.2020.100666
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background: Clinical trial monitoring is an essential activity for quality assurance (QA) to ensure the protection of human rights and the reliability and transparency of the data collection process. The purpose of this article is to enhance the understanding of monitoring process and major findings in clinical trials of complementary and alternative medicine (CAM). Methods: Based on International Conference on Harmonization of technical requirements for registration of pharmaceuticals for human use (ICH-GCP), we summarized main concept of monitoring process. Personal experiences on monitoring for CAM studies were also narratively described. Results: In this brief article, the basic concept of QA and quality control (QC), various monitoring activities during the study process, and major findings regarding clinical trials of CAM are suggested in an effort to improve understanding of monitoring in clinical research on CAM. Conclusion: When performing clinical trials for CAM-related interventions, the monitoring recommended in GCP is needed to be recognized as a mandatory element in the course of CAM research. (C) 2020 Korea Institute of Oriental Medicine. Publishing services by Elsevier B.V.
引用
收藏
页数:4
相关论文
共 10 条
[1]   Ensuring trial validity by data quality assurance and diversification of monitoring methods [J].
Baigent, Colin ;
Harrell, Frank E. ;
Buyse, Marc ;
Emberson, Jonathan R. ;
Altman, Douglas G. .
CLINICAL TRIALS, 2008, 5 (01) :49-55
[2]   Researching complementary and alternative treatments - the gatekeepers are not at home [J].
Fonnebo, Vinjar ;
Grimsgaard, Sameline ;
Walach, Harald ;
Ritenbaugh, Cheryl ;
Norheim, Arne Johan ;
MacPherson, Hugh ;
Lewith, George ;
Launso, Laila ;
Koithan, Mary ;
Falkenberg, Torkel ;
Boon, Heather ;
Aickin, Mikel .
BMC MEDICAL RESEARCH METHODOLOGY, 2007, 7 (1)
[3]  
Food U, 2018, E6 R2 GOOD CLIN PRAC
[4]  
Guideline IH, 2015, Current Step, V2, P1
[5]   Systematic reviews in health care -: Assessing the quality of controlled clinical trials [J].
Jüni, P ;
Altman, DG ;
Egger, M .
BMJ-BRITISH MEDICAL JOURNAL, 2001, 323 (7303) :42-46
[6]  
Kim S-m, 2011, STUDY WORKLOAD TASK, P4
[7]   The impact of clinical trial monitoring approaches on data integrity and cost-a review of current literature [J].
Olsen, Rasmus ;
Bihlet, Asger Reinstrup ;
Kalakou, Faidra ;
Andersen, Jeppe Ragnar .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (04) :399-412
[8]  
RICKHAM PP, 1964, BRIT MED J, V2, P173
[9]  
Schuyl ML, 1999, DRUG INF J, V33, P789, DOI 10.1177/009286159903300319
[10]   Patterns of DNA Methylation in Development, Division of Labor and Hybridization in an Ant with Genetic Caste Determination [J].
Smith, Chris R. ;
Mutti, Navdeep S. ;
Jasper, W. Cameron ;
Naidu, Agni ;
Smith, Christopher D. ;
Gadau, Juergen .
PLOS ONE, 2012, 7 (08)